One of these proteins, BCL6, when mutated, drives the blood cancer known as diffuse large cell B-cell lymphoma. This kind of cancer-driving protein is also referred to as an oncogene. In lymphoma ...

Similar therapies could also be used to treat other populations prone to muscle loss, such as older adults and patients with systemic diseases like sepsis or cancer ... of BCL6 in muscle cells ...

This discovery could lead to innovative treatments for conditions like aging, cancer cachexia ... they found that muscle cells contain high levels of a protein called BCL6, suggesting it may ...

Similar therapies could also be used to treat other populations prone to muscle loss, such as older adults and patients with systemic diseases like sepsis or cancer ... of BCL6 in muscle cells ...

Similar therapies could also be used to treat other populations prone to muscle loss, such as older adults and patients with systemic diseases like sepsis or cancer ... of BCL6 in muscle cells ...

Muscle mass plays a crucial role in overall health, strength, and metabolic function, making its regulation essential for maintaining quality of life. A re | Cell And Molecular Biology ...

This same kind of BCL6 therapy has the potential to help a wider population, such as older adults and those with muscle-impacting conditions including cancer. The research was published in the ...